Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-14

Clinical Trial Update: Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the PISCES I trial evaluating nicotine replacement therapy, counseling, varenicline, and bupropion for smoking cessation, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Counseling
  • Nicotine replacement therapy (nicotine replacement therapy)
  • Varenicline (varenicline)
  • bupropion (bupropion)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cigarette Smoking-Related Carcinoma | Phase 4 | Status: RECRUITING